Skip To Main Content

Search

For optimal search results, please limit to 2 product keywords

If you are searching for information related to a product:

  • For optimal results, please enter at least 2 search terms in addition to product name
  • Example: [product name] [search term] [search term]
  • Example: Product + clinical trials
  • For an exact match, please include search terms in double quotations. For example: "Elevatum"

    Please enter search terms.

    Our Rheumatology Portfolio

    Find product and prescribing information, as well as other resources, for Genentech’s rheumatology portfolio below.

    A

    Actemra®

    (tocilizumab)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    ACTEMRA® SC Autoinjector (162 mg/0.9 mL)
    ACTEMRA® Sterile Concentrate for Injection (80 mg)
    ACTEMRA® SC Prefilled Syringes (162 mg/0.9 mL)
    ACTEMRA® Sterile Concentrate for Injection (200 mg)
    ACTEMRA® Sterile Concentrate for Injection (400 mg)

    Healthcare Provider Letters:

    Important Prescribing Information - Temporary Supply Shortage Actemra 20 mg/mL Concentrate for Solution for Infusion (IV) - September 2021
    Apr 2020 - Shipping short-dated Actemra (tocilizumab) 400 mg/20 mL vial for IV with dark blue cap
    Important Drug Warning - 2019
    IMPORTANT SAFETY INFORMATION Regarding ACTEMRA® (tocilizumab) REMS, October 2013
    Actemra for RA and SJIA - June 2011
    Actemra for RA and SJIA - Oct 2012

    R

    Rituxan®

    (rituximab)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    RITUXAN® Vials (100 mg/10 mL)
    RITUXAN® Vials (500 mg/50 mL)

    Healthcare Provider Letters:

    Rituxan® (rituximab) Label: Hepatitis B Reactivation - October 2013
    Important Drug Warning: Updated Safety Information - Dec 2006
    Important Drug Warning: New Safety Information - Sept 2008
    Important Drug Warning: Updated Safety Information - Oct 2009
    Publications icon

    Publications

    Visit PubMed.gov to view scientific literature for Genentech rheumatology portfolio products.

    Actemra® at PubMed.gov

    Rituxan® at PubMed.gov

    Scientific congresses icon

    Scientific Congresses

    Genentech maintains a presence at in-person and virtual scientific congresses worldwide. Find Genentech-sponsored posters and presentations from recent congresses at Medically.gene.com.

    Clinical trials icon

    Clinical Trials

    Find information about active clinical research for Genentech rheumatology portfolio products.

    Actemra® at ClinicalTrials.gov

    Rituxan® at ClinicalTrials.gov

    Additional resources icon

    Additional Resources

    Connect with a Medical Science Liaison

    Browse the Genentech Medical Information Library

    Information about Actemra® EUA for the treatment of COVID-19